These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 25110404)

  • 1. Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.
    Ansaldi F; Orsi A; Sticchi L; Bruzzone B; Icardi G
    World J Gastroenterol; 2014 Aug; 20(29):9633-52. PubMed ID: 25110404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus infection: Are there still specific problems with genotype 3?
    Gondeau C; Pageaux GP; Larrey D
    World J Gastroenterol; 2015 Nov; 21(42):12101-13. PubMed ID: 26576095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of pediatric hepatitis C.
    El-Shabrawi MH; Kamal NM
    World J Gastroenterol; 2013 Nov; 19(44):7880-8. PubMed ID: 24307782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.
    Preciado MV; Valva P; Escobar-Gutierrez A; Rahal P; Ruiz-Tovar K; Yamasaki L; Vazquez-Chacon C; Martinez-Guarneros A; Carpio-Pedroza JC; Fonseca-Coronado S; Cruz-Rivera M
    World J Gastroenterol; 2014 Nov; 20(43):15992-6013. PubMed ID: 25473152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenetic studies of the hepatitis C virus infection in an era of pan-genotype antiviral therapies - Effective treatment is coming.
    Ellwanger JH; Kaminski VL; Valverde-Villegas JM; Simon D; Lunge VR; Chies JAB
    Infect Genet Evol; 2018 Dec; 66():376-391. PubMed ID: 28811194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closing the Gap: The Challenges of Treating Hepatitis C Virus Genotype 3 Infection.
    Martin MT; Deming P
    Pharmacotherapy; 2017 Jun; 37(6):735-747. PubMed ID: 28374965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New hepatitis C therapies: the toolbox, strategies, and challenges.
    Pawlotsky JM
    Gastroenterology; 2014 May; 146(5):1176-92. PubMed ID: 24631495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic determinants of hepatitis C virus antiviral therapy outcomes: toward individualized treatment.
    Venegas M; Brahm J; Villanueva RA
    Ann Hepatol; 2012; 11(6):827-37. PubMed ID: 23109445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral treatment of hepatitis C virus infection and factors affecting efficacy.
    Zhu Y; Chen S
    World J Gastroenterol; 2013 Dec; 19(47):8963-73. PubMed ID: 24379621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus vaccines in the era of new direct-acting antivirals.
    Shi C; Ploss A
    Expert Rev Gastroenterol Hepatol; 2013 Feb; 7(2):171-85. PubMed ID: 23363265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis, diagnosis and management of hepatitis C.
    Boyer N; Marcellin P
    J Hepatol; 2000; 32(1 Suppl):98-112. PubMed ID: 10728798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from
    Sahuc ME; Sahli R; Rivière C; Pène V; Lavie M; Vandeputte A; Brodin P; Rosenberg AR; Dubuisson J; Ksouri R; Rouillé Y; Sahpaz S; Séron K
    J Virol; 2019 May; 93(10):. PubMed ID: 30842319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C: Is eradication possible?
    Lombardi A; Mondelli MU;
    Liver Int; 2019 Mar; 39(3):416-426. PubMed ID: 30472772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C eradication: A long way to go.
    Waheed Y
    World J Gastroenterol; 2015 Nov; 21(43):12510-2. PubMed ID: 26604658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scotomas in molecular virology and epidemiology of hepatitis C virus.
    Wang Y
    World J Gastroenterol; 2013 Nov; 19(44):7910-21. PubMed ID: 24307785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype 3 Infection: The Last Stand of Hepatitis C Virus.
    Chan A; Patel K; Naggie S
    Drugs; 2017 Feb; 77(2):131-144. PubMed ID: 28074358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL28B polymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients.
    Rosso C; Abate ML; Ciancio A; Strona S; Caviglia GP; Olivero A; Touscoz GA; Rizzetto M; Pellicano R; Smedile A
    World J Gastroenterol; 2014 Sep; 20(36):13146-52. PubMed ID: 25278709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput approaches to unravel hepatitis C virus-host interactions.
    Colpitts CC; El-Saghire H; Pochet N; Schuster C; Baumert TF
    Virus Res; 2016 Jun; 218():18-24. PubMed ID: 26410623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus core antigen testing: role in diagnosis, disease monitoring and treatment.
    Tillmann HL
    World J Gastroenterol; 2014 Jun; 20(22):6701-6. PubMed ID: 24944462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.